Literature DB >> 8299482

Clinical pharmacology of human insulin.

L Heinemann1, B Richter.   

Abstract

Nowadays, human insulin is used daily by millions of diabetic patients. The biological effect of human insulin is comparable to that of porcine insulin. However, after subcutaneous injection, pharmacological and clinical studies showed pharmacokinetic and pharmacodynamic differences between human and animal insulins. Human insulin tends to have faster absorption and shorter duration of action compared with animal insulin. These differences are more pronounced and can be of clinical relevance with intermediate- and long-acting insulin preparations. Optimal metabolic control can be achieved with either human or highly purified animal insulin preparations, provided appropriate insulin replacement strategies are used.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8299482     DOI: 10.2337/diacare.16.3.90

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

Review 1.  Pharmacokinetic considerations of new insulin formulations and routes of administration.

Authors:  A Hoffman; E Ziv
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 2.  Insulin therapy in children and adolescents with type 1 diabetes.

Authors:  Faisal S Malik; Craig E Taplin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 3.  A critical appraisal of the role of insulin analogues in the management of diabetes mellitus.

Authors:  Ralph Oiknine; Marla Bernbaum; Arshag D Mooradian
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  A rational approach to drug therapy of type 2 diabetes mellitus.

Authors:  J M Chehade; A D Mooradian
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 5.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

6.  Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms.

Authors:  G Kotzke; M Schütt; U Missler; D E Moller; H L Fehm; H H Klein
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

Review 7.  Intensive diabetes management in pediatric patients.

Authors:  B Buckingham; B Bluck; D M Wilson
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

Review 8.  Insulin glargine in the treatment of type 1 and type 2 diabetes.

Authors:  Anthony H Barnett
Journal:  Vasc Health Risk Manag       Date:  2006

9.  PROGENS-HbA1c study: safety and effectiveness of premixed recombinant human insulin (Gensulin M30).

Authors:  Magdalena Walicka; Jacek Jóźwiak; Jacek Rzeszotarski; Grażyna Zarzycka-Lindner; Anna Zonenberg; Paweł Bijoś; Małgorzata Masierek; Edward Franek
Journal:  Arch Med Sci       Date:  2016-08-24       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.